Physician profile
Richard Hunter Bone
NPI 1407887938
$33,755.06
in general payments reported to CMS, 2019-2025
15 companies · $7,038 in 2025
The $7,038 reported for 2025 was more than what 92% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,113 · 2020: $87.36 · 2021: $67.65 · 2022: $1,242 · 2023: $1,449 · 2024: $18K · 2025: $7,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $3,541 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,100 · Food and Beverage: $2,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,556.00 |
| Travel and Lodging | $3,541.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,100.00 |
| Food and Beverage | $2,047.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14,738.47 | 2021-2025 | General - Therapies, Axios, Spyglass |
| Genzyme Corporation | $8,454.21 | 2024 | |
| Pfizer INC. | $8,250.81 | 2019-2025 | |
| Genentech USA, INC. | $1,075.00 | 2022 | |
| Merck Sharp & Dohme LLC | $323.28 | 2019-2025 | |
| Novo Nordisk INC | $162.25 | 2023-2025 | |
| Conmed Corporation | $134.46 | 2024 | Conmed Hemostasis, Conmed Generators |
| Exact Sciences Corporation | $121.28 | 2023-2024 | Cologuard Collection Kit |
| Cook Medical LLC | $120.26 | 2023 | Hemospray |
| Endogastric Solutions, INC | $93.91 | 2023 | Esophyx |
| Sanofi US Services INC. | $92.07 | 2023 | |
| Medtronic, INC. | $86.51 | 2024 | Endoflip |
| Abbvie INC. | $46.32 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.95 | 2022 | |
| Johnson & Johnson Health Care Systems INC. | $25.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.